These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 26575421

  • 21. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW, Medina-Pérez WY, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz AM, Ross DD, Bates SE.
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y, Zhang Y, Zhang W, Sun C, Wu J, Tang J.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():60-9. PubMed ID: 26655793
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
    Pan ZZ, Wang HY, Zhang M, Lin TT, Zhang WY, Zhao PF, Tang YS, Xiong Y, Zeng YE, Huang YZ.
    Acta Pharmacol Sin; 2016 Aug 01; 37(8):1110-20. PubMed ID: 27292613
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
    Zhou H, Lv S, Zhang D, Deng M, Zhang X, Tang Z, Chen X.
    Acta Biomater; 2018 Jun 01; 73():388-399. PubMed ID: 29694920
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M.
    Breast Cancer Res Treat; 2013 Jun 01; 139(3):717-30. PubMed ID: 23780685
    [Abstract] [Full Text] [Related]

  • 33. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.
    Cheng C, Liu ZG, Zhang H, Xie JD, Chen XG, Zhao XQ, Wang F, Liang YJ, Chen LK, Singh S, Chen JJ, Talele TT, Chen ZS, Zhong FT, Fu LW.
    Mol Pharm; 2012 Jul 02; 9(7):1971-82. PubMed ID: 22632055
    [Abstract] [Full Text] [Related]

  • 34. Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy.
    Jin W, Wang Q, Wu M, Li Y, Tang G, Ping Y, Chu PK.
    Biomaterials; 2017 Jun 02; 129():83-97. PubMed ID: 28329693
    [Abstract] [Full Text] [Related]

  • 35. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M, Li J, Lin X, Wei Z, Zhang D, Zhao B, Liu X, Liu J.
    Biomater Sci; 2018 May 29; 6(6):1457-1468. PubMed ID: 29770812
    [Abstract] [Full Text] [Related]

  • 36. Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells.
    Lin G, Zhu W, Yang L, Wu J, Lin B, Xu Y, Cheng Z, Xia C, Gong Q, Song B, Ai H.
    Biomaterials; 2014 Nov 29; 35(35):9495-507. PubMed ID: 25155545
    [Abstract] [Full Text] [Related]

  • 37. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
    Zhang X, Li F, Guo S, Chen X, Wang X, Li J, Gan Y.
    Biomaterials; 2014 Apr 29; 35(11):3650-65. PubMed ID: 24462359
    [Abstract] [Full Text] [Related]

  • 38. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
    Li T, Kong AN, Ma Z, Liu H, Liu P, Xiao Y, Jiang X, Wang L.
    Oncotarget; 2016 Apr 12; 7(15):20236-48. PubMed ID: 26934120
    [Abstract] [Full Text] [Related]

  • 39. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter.
    Qiu JG, Zhang YJ, Li Y, Zhao JM, Zhang WJ, Jiang QW, Mei XL, Xue YQ, Qin WM, Yang Y, Zheng DW, Chen Y, Wei MN, Shi Z.
    Oncotarget; 2015 Jun 20; 6(17):15494-509. PubMed ID: 25915534
    [Abstract] [Full Text] [Related]

  • 40. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
    Duan J, Mansour HM, Zhang Y, Deng X, Chen Y, Wang J, Pan Y, Zhao J.
    Int J Pharm; 2012 Apr 15; 426(1-2):193-201. PubMed ID: 22274587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.